We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1251
Tenet Healthcare
THC
$21.1B
$13K ﹤0.01%
+580
New +$12.4K
KRA
1252
DELISTED
Kraton Corporation
KRA
$13K ﹤0.01%
+408
New +$12.2K
MOS icon
1253
The Mosaic Company
MOS
$7.33B
$12K ﹤0.01%
601
-640,935
-100% -$14M
NMM icon
1254
Navios Maritime Partners
NMM
$2.26B
$12K ﹤0.01%
+644
New +$10.7K
AXTI icon
1255
AXT Inc
AXTI
$5.8B
$11K ﹤0.01%
+3,021
New +$11.6K
CMRE icon
1256
Costamare
CMRE
$1.77B
$11K ﹤0.01%
+1,764
New +$10.2K
EPR icon
1257
EPR Properties
EPR
$4.77B
$11K ﹤0.01%
+149
New +$11.3K
LEVI icon
1258
Levi Strauss
LEVI
$9.39B
$11K ﹤0.01%
601
-12,896
-96% -$239K
DTIL icon
1259
Precision BioSciences
DTIL
$207M
$10K ﹤0.01%
40
-896
-96% -$292K
HCKT icon
1260
Hackett Group
HCKT
$287M
$10K ﹤0.01%
+628
New +$10.3K
TTOO
1261
DELISTED
T2 Biosystems, Inc
TTOO
$10K ﹤0.01%
+1
New +$8.03K
ARES icon
1262
Ares Management
ARES
$30.9B
$9K ﹤0.01%
+342
New +$9.78K
GLP icon
1263
Global Partners
GLP
$1.7B
$9K ﹤0.01%
481
-10,095
-95% -$198K
IRS
1264
IRSA Inversiones y Representaciones
IRS
$1.26B
$9K ﹤0.01%
+1,734
New +$13.8K
MNTA
1265
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9K ﹤0.01%
+710
New +$8.57K
CIVI
1266
DELISTED
Civitas Resources
CIVI
$8K ﹤0.01%
+376
New +$8.37K
USDP
1267
DELISTED
USD PARTNERS LP
USDP
$8K ﹤0.01%
+800
New +$8.74K
DRNA
1268
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$8K ﹤0.01%
+515
New +$7.36K
GOTU icon
1269
Gaotu Techedu
GOTU
$436M
$7K ﹤0.01%
+431
New +$5.47K
HBIO icon
1270
Harvard Bioscience
HBIO
$29.2M
$7K ﹤0.01%
+241
New +$5.99K
PCAR icon
1271
PACCAR
PCAR
$70.1B
$6K ﹤0.01%
+125
New +$5.7K
GLOP
1272
DELISTED
GASLOG PARTNERS LP
GLOP
$6K ﹤0.01%
+338
New +$6.76K
CHK
1273
DELISTED
Chesapeake Energy Corporation
CHK
$6K ﹤0.01%
23
-195
-89% -$63.4K
IT icon
1274
Gartner
IT
$11.7B
$5K ﹤0.01%
+32
New +$4.65K
LEGH icon
1275
Legacy Housing
LEGH
$694M
$5K ﹤0.01%
+329
New +$4.51K
49 50
51
52 53

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.